On June 14th, Gelunhui reported that Wuhan Keqian Biology Co., Ltd. (688526.SH) announced that Mr. Ye Changfa, a shareholder and supervisor holding more than 5% of the company's shares, intends to reduce his shareholding by no more than 6,876,535 shares, or no more than 1.48% of the total share capital of the company, through a combination of centralized bidding and bulk trading to meet his own capital needs. The proportion of the total number of company shares held before the reduction does not exceed 25%.

Among them, it is planned to reduce no more than 4,661,680 shares through centralized bidding, accounting for no more than 1.00% of the company's total share capital, and the total number of shares to be divested in any consecutive 90 natural days will not exceed 1.00% of the company's total shares; it is planned to reduce no more than 6,876,535 shares through bulk trading, accounting for no more than 1.48% of the company's total share capital, and the total number of shares to be divested in any consecutive 90 natural days will not exceed 2.00% of the company's total shares. This plan will be implemented within three months after 15 trading days from the date of this announcement. The reduction price will be determined based on the market price.